|
Plant Physiol, November 2002, Vol. 130, pp. 1077-1078
THE HOT AND THE CLASSIC
 |
Lycopene and the Prevention of Prostate Cancer: The Love Apple
Lives up to Its Name |
Humans cannot synthesize
carotenoids de novo and must attain these micronutrients exclusively
through their diets. Although the necessity for -carotene as the
precursor of vitamin A has been recognized for many years, it is
lycopene, a carotenoid that lacks provitamin A activity, that has
attracted the most attention of late. Lycopene is the pigment
principally responsible for the deep-red color of ripe tomato
(Lycopersicon esculentum) fruits and tomato products.
Tomato products, including ketchup, tomato juice, and pizza sauce, are
the richest sources of lycopene in the U.S. diet, accounting for >80%
of the total lycopene intake of Americans (the average
American eats 9 kg of fresh tomatoes and 33 kg of processed tomato
products each year). The consumption of tomatoes and tomato products
containing lycopene have been shown to be associated with decreased
risk of chronic diseases such as cancer and cardiovascular diseases in
several recent studies. Many have attributed the health benefits of
lycopene to its antioxidant properties (lycopene quenches singlet
oxygen almost twice as well as -carotene does), although other
mechanisms of lycopene action are possible: The modulation of
intercellular communication, hormonal and immune system changes, and
alterations of metabolic pathways may also be involved (Rao and
Agarwal, 2000 ).
 |
Lycopene and Human Health |
Giovannucci et al. (1995) examined the
relationship between the intake of various carotenoids, fruits, and
vegetables and the risk of prostate cancer. A dietary questionnaire was
sent to almost 50,000 participants in the Health Professional Follow-up Study (HPFS) who were initially free of diagnosed cancer in 1986. Follow-up questionnaires were sent to the entire cohort in 1988, 1990, and 1992. During this period, 812 new cases of prostate cancer were
documented within the study group. Of the 46 vegetables and
fruits or related products that were analyzed, only four were significantly associated with lower prostate cancer risk. Of the four,
tomato sauce (P < 0.001), tomatoes
(P < 0.03), and pizza (P < 0.05), but not strawberries, were primary sources of lycopene. Intakes
of the carotenoids -carotene, -carotene, lutein, and -cryptoxanthin were not associated with risk of prostate cancer; only lycopene intake was related to lower risk. These findings suggest
that tomato-based foods may be especially beneficial in reducing
prostate cancer risk. Of course, other interpretations are possible.
For example, perhaps those ethnic groups that traditionally eat more
tomato products might be inherently less susceptible to prostate cancer
or, alternatively, perhaps those people who eat plenty of tomatoes
might also eat plenty of cancer-preventing vegetables in general. More
recently, however, Giovannucci et al. (2002) have
updated their HPFS study and re-confirmed their earlier results.
Moreover, they have found that the associations they uncovered
persisted in analyses controlling for fruit and vegetable consumption
and for olive oil use (a marker for Mediterranean diet) and were
observed separately in men of Southern European or other Caucasian ancestry.
The link between lycopene and the prevention of prostate cancer is also
supported by studies that have examined the plasma levels of lycopenes
in humans. Lycopene was the only antioxidant that occurred at
significantly lower levels in men who went on to develop prostate
cancer in comparison with status-matched controls (Gann et al.,
1999 ).
The health benefits of lycopene might extend beyond fighting prostate
cancer. Accumulating evidence suggests that the anti-proliferative properties of lycopene may extend to other types of cancer
(Giovannucci, 1999 ). Moreover, lycopene may also be
useful in preventing heart disease. Lycopene apparently inhibits
cholesterol synthesis and enhances low-density lipoprotein degradation.
Available evidence suggests that the thickness of the innermost wall of
blood vessels and the risk of myocardial infarction are reduced in
persons with higher adipose tissue concentrations of lycopene
(Arab and Steck, 2000 ).
 |
Processed Tomatoes Are Even Better |
It may seem peculiar that tomato paste and other processed
tomato products are more effective than fresh tomatoes in preventing prostate cancer. Processed fruits and vegetables have been long considered to have lower nutritional value than their fresh commodities due to the loss of vitamin C during processing. Numerous studies, however, have revealed that tomato processing increases the
bioavailability of lycopene to humans (Gartner et al.,
1997 ). Lycopene in fresh tomato fruits occurs almost entirely
in the all-trans configuration, but processing converts much of it to
cis-forms (Shi and Le Maguer, 2000 ), and it is these
cis-forms that are taken up more readily by humans (Gartner et
al., 1997 ). Indeed, in striking contrast with foods, all-trans
lycopene accounts for only 12% to 21% and cis-isomers for 79% to
88% of total lycopene in prostate tissues (Clinton et al.,
1996 ).
 |
Lycopene Production |
Due to the spate of recent reports that have suggested an
important role for lycopene in human health, consumer demand for lycopene-rich food and nutraceutical products is growing. This increased demand, in turn, has fueled research into identifying alternative lycopene-rich sources and into finding ways to
increase lycopene production in tomato fruits. In regard to
the first strategy, Fordham et al. (2001) have reported
that autumn olive (Elaeagnus umbellata), which has
edible fruit, is an extremely rich source of lycopene: Its
berries contain lycopene at 15 to 54 mg per 100 g fresh fruit. In
contrast, fresh tomato fruit typically has a lycopene content of about
3 mg 100 g 1. This newly identified source of lycopene may
provide an alternative to tomato as a dietary source of lycopene.
Our understanding of the physiology underlying lycopene
production is still fragmentary. It is known that ethylene, the hormone most associated with ripening, is required for lycopene production in
tomato fruits (Theologis et al., 1993 ).
Phytochrome also plays an important role in lycopene
production. Brief red-light treatment of harvested
mature-green fruit stimulated lycopene accumulation 2.3-fold during
fruit development. This red light-induced lycopene accumulation was
reversed by subsequent treatment with far-red light, establishing that
light-induced accumulation of lycopene in tomato is regulated by
fruit-localized phytochromes (Alba et al., 2000 ).
Recently, Mehta et al. (2002) reported that lycopene levels were increased in tomato fruits transgenically engineered to
produce higher levels of the polyamines spermine and spermidine during ripening.
Molecular biology has also provided important insights into
lycopene biosynthesis. Molecular analyses of yellow-fruited tomato mutants has shown that the lack of carotenoids in the fruits of these
mutants is due to the production of aberrant TOM5
transcripts that encode for dysfunctional phytoene synthase
(Fray and Grierson, 1993 ). More recently, Fraser et al.
(2002) overexpressed phytoene synthase from the
bacterium Erwinia uredovora (crtB) in
tomato fruits. Total fruit carotenoids of primary transformants were 2- to 4-fold higher than the controls, and lycopene levels were approximately doubled. Ronen et al. (2000) analyzed two
mutations that affect fruit pigmentation in tomato: Beta
(B), a single dominant gene that increases -carotene
in the fruit, and old-gold (og), a
recessive mutation that increases lycopene and lowers -carotene levels. Molecular analyses revealed that B encodes a
novel type of lycopene -cyclase, an enzyme that converts lycopene to
-carotene, suggesting that -carotene is synthesized de novo
during tomato fruit development by the -lycopene cyclase. In
wild-type tomatoes, B is expressed at low levels during
the breaker stage of ripening, whereas in the Beta
mutant its transcription is dramatically increased. Null mutations in
the gene B are responsible for the phenotype in
og, indicating that og is an allele of
B. These results confirm that developmentally regulated
transcription is the major mechanism that governs lycopene accumulation
in ripening fruits.
 |
FOOTNOTES |
www.plantphysiol.org/cgi/doi/10.1104/ pp.900054.
 |
LITERATURE CITED |
-
Alba R, Cordonnier-Pratt MM, Pratt LH
(2000)
Fruit-localized phytochromes regulate lycopene accumulation independently of ethylene production in tomato.
Plant Physiol
123: 363-370[Abstract/Free Full Text]
-
Arab L, Steck S
(2000)
Lycopene and cardiovascular disease.
Am J Clin Nutr
71: 1691S-1695S[Abstract/Free Full Text]
-
Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW
(1996)
cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
Cancer Epidemiol Biomarkers Prev
5: 823-833[Abstract]
-
Fordham IM, Clevidence BA, Wiley ER, Zimmerman RH
(2001)
Fruit of Autumn olive: a rich source of lycopene.
Hortscience
36: 1136-1137
-
Fraser PD, Romer S, Shipton CA, Mills PB, Kiano JW, Misawa N, Drake RG, Schuch W, Bramley PM
(2002)
Evaluation of transgenic tomato plants expressing an additional phytoene synthase in a fruit-specific manner.
Proc Natl Acad Sci USA
99: 1092-1097[Abstract/Free Full Text]
-
Fray RG, Grierson D
(1993)
Identification and genetic analysis of normal and mutant phytoene synthase genes of tomato by sequencing, complementation and co-suppression.
Plant Mol Biol
22: 589-602[CrossRef][ISI][Medline]
-
Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ
(1999)
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Cancer Res
59: 1225-1230[Abstract/Free Full Text]
-
Gartner C, Stahl W, Sies H
(1997)
Lycopene is more bioavailable from tomato paste than from fresh tomatoes.
Am J Clin Nutr
66: 116-122[Abstract/Free Full Text]
-
Giovannucci E
(1999)
Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature.
J Natl Cancer Inst
91: 317-331[Abstract/Free Full Text]
-
Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC
(1995)
Intake of carotenoids and retinol in relation to risk of prostate cancer.
J Natl Cancer Inst
87: 1767-1776[Abstract/Free Full Text]
-
Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC
(2002)
A prospective study of tomato products, lycopene, and prostate cancer risk.
J Natl Cancer Inst
94: 391-398[Abstract/Free Full Text]
-
Mehta RA, Cassol T, Li N, Ali N, Handa AK, Mattoo AK
(2002)
Engineered polyamine accumulation in tomato enhances phytonutrient content, juice quality, and vine life.
Nat Biotechnol
20: 613-618[CrossRef][ISI][Medline]
-
Rao AVR, Agarwal S
(2000)
Role of antioxidant lycopene in cancer and heart disease.
J Am Coll Nutr
19: 563-569[Abstract/Free Full Text]
-
Ronen G, Carmel-Goren L, Zamir D, Hirschberg J
(2000)
An alternative pathway to
-carotene formation in plant chromoplasts discovered by map-based cloning of Beta and old-gold color mutations in tomato.
Proc Natl Acad Sci USA
97: 11102-11107[Abstract/Free Full Text] -
Shi J, Le Maguer M
(2000)
Lycopene in tomatoes: chemical and physical properties affected by food processing.
Crit Rev Biotech
20: 293-334[CrossRef][ISI][Medline]
-
Theologis A, Oeller PW, Wong LM, Rottmann WH, Gantz DM
(1993)
Use of a tomato mutant constructed with reverse genetics to study fruit ripening, a complex developmental process.
Dev Genet
14: 282-295[CrossRef][ISI][Medline]
Peter V. Minorsky
Department of Natural Sciences Mercy College Dobbs Ferry, NY 10522
© 2002 American Society of Plant Biologists
This article has been cited by other articles:

|
 |

|
 |
 
J. W. FINLEY
Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
Ann. Bot.,
June 1, 2005;
95(7):
1075 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Forbes, K. Gillette, and I. Sehgal
Lycopene Increases Urokinase Receptor and Fails to Inhibit Growth or Connexin Expression in a Metastatically Passaged Prostate Cancer Cell Line: A Brief Communication
Experimental Biology and Medicine,
September 1, 2003;
228(8):
967 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|